Aptamer Group PLC (AIM:APTA)

Revenue by Segment

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Mar 31, 2020	Mar 31, 2019
Research and Experimental Development of Biotechnology	1.20M	860.00K	1.75M	4.04M	1.28M
Research and Experimental Development of Biotechnology Growth	39.88%	-50.91%	-56.59%	215.31%	49.78%
Total	1.20M	860.00K	1.75M	4.04M	1.28M
Total Growth	39.88%	-50.91%	-56.59%	215.31%	49.78%

Revenue by Geography

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Mar 31, 2020	Mar 31, 2019
United Kingdom	235.00K	143.00K	427.00K	597.00K	290.40K
United Kingdom Growth	64.34%	-66.51%	-28.48%	105.58%	92.01%
Europe	239.00K	14.00K	134.00K	325.00K	145.60K
Europe Growth	1607.14%	-89.55%	-58.77%	123.21%	75.67%
Rest of The World	10.00K	110.00K	165.00K	3.11M	844.00K
Rest of The World Growth	-90.91%	-33.33%	-94.70%	268.96%	36.03%
United States of America	719.00K	593.00K	1.03M	-	-
United States of America Growth	21.25%	-42.20%	-	-	-
Total	1.20M	860.00K	1.75M	4.04M	1.28M
Total Growth	39.88%	-50.91%	-56.59%	215.31%	49.78%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 6, 2026

Data Sources Report a data error